News Focus
News Focus
icon url

Carboat

12/01/16 3:49 PM

#280068 RE: biopharm #280038

You think a 350% gain in next quarter?
icon url

Protector

12/02/16 6:10 AM

#280096 RE: biopharm #280038

biopharm, maybe there should be some 'limit' on fantasy. Not that I don't like it but for certain of your suggestion to happen, or even to be considered, there must be a PPHM/Bavituximab awareness...and still then several of the dream scenarios, IMO, are not even considering-grade for the people involved that could make them happen. If you have a well cushioned seat you mostly don't make moves that could land you on a wooden chair.

I have posted in the past that PPHM keeps a very low profile at such extend that the public is hardly aware of its existence. The PPS that you see today is not one that could exist if PPHM was traded daily by a few 100K people world-wide.

Today most people do not know PPHM and if they know it then only a hand full of them has the D&D knowledge of some posters on here which is needed to understand the potential of this stock. That is what makes PPHM stock so popular for manipulation because once you realise the potential it doesn't take Blackrock-depth pockets to move it. And the motto is and will always be buy low and sell high.

Shorting will soon or later disappear when nations realise that they are loosing control of their crown jewels and hence will restore the good old PERFORMANCE-INVESTMENT RETURN system. Always think that those that manipulate stock and in a selfish way organise the give-away of the Nations key-corporations can (and will) leave because they made the cash before things collapse but Joe Do must stay! And governments don't want unhappy Joe Do's in to large amounts. It is just a matter of time.

PPHM is at it's depth and a shake-out was expected sooner or later. People think that a shake-out is a strong dip down and then back up but it isn't (that is a wash & rinse and mostly aimed at day/swing traders to force them to take their losses). A shake-out is TIME BASED. It has been established that we ALL have certain thresholds ranging from weak-hands to die-hards. You don't shake them out with a DIP. You go for exhaustion, kind of like in a lawsuit that you can win because of your pocket depth and the inability of the other party to keep up the legal cost.

As a study topic for PPHM (while there is not much other D&D that can be done as long as we don't have NEW NEWS from PPHM) one could study the micro-sentiment on PPHM on this board. You can easily filter out the die-hards (i myself am in that category) and mood-swingers that have a PPS related mood, the patient realists that know that the underlying company is important not the smoke on top of it and hence looks for the end-result, the traders that have a short-time view each time they open a position, etc.

In a way this should be a reflection of what is out there and trades PPHM, or will trade PPHM, when the stock gets more popular in H1/2017. And that will explain why the PPS makes those waves up and down because you have that rich mix of people whose fear/greed thresholds are reached at different PPHM price points.

The parties that you name as potential candidates for the scenarios have a budget to tie. Except for a few exceptions that have to report. While we may not see PPHM as the high risk small cap it w-once was due to its curent cash position, no more loans or creditors, 100% owner of IP and Pipelines in an unencumbered way, steady and doubling income on a yearly basis for 3rd party manufacturing and growing, ATM and PPHM contingency means, recognition by Scientific world of Bavituximab being a Global/Upstream/Systemic vs a Local/Downstream checkpoint, the consistently good results of Bavituximab, even if not approved due to regulation, then collaboration and recognition from world class research centres such as Memorial Sloan Kettering, Moffit, Wistar, UTSW and other with their KOLs (Key Opinion Leader) actively participating and not just siting in a commit for marketing reasons, etc.

On Wall St ONLY those specifically following PPHM will now this but for most we are JUST a TICKER symbol on the generic term of R&D and oncology pipeline with NO DRUG on the market. It is very likely that Avid isn't even mentioned.

PPHMP is the GIVE-AWAY: It's price varies between 2.5 to 3$ per equivalent common share. That is because PPHM CANNOT easily be manipulated without big losses while the common PPHM share can. But believe me if the PPHMP common would NOT be worth at least that price and a risk for BK would exist then the PPHMP would have been down because of investors leaving. The interest of the series cannot make up for a large capital loss.